Bukwang Pharm - Asset Resilience Ratio

Latest as of September 2025: 39.75%

Bukwang Pharm (003000) has an Asset Resilience Ratio of 39.75% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of Bukwang Pharm to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩188.03 Billion

≈ $127.42 Million USD Cash + Short-term Investments

Total Assets

₩472.99 Billion

≈ $320.54 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2007–2024)

This chart shows how Bukwang Pharm's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Bukwang Pharm total assets.

Liquid Assets Composition Over Time

This chart breaks down Bukwang Pharm's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 003000 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩188.03 Billion	39.75%
Total Liquid Assets	₩188.03 Billion	39.75%

Asset Resilience Insights

Very High Liquidity: Bukwang Pharm maintains exceptional liquid asset reserves at 39.75% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Bukwang Pharm Industry Peers by Asset Resilience Ratio

Compare Bukwang Pharm's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Viatris Inc NASDAQ:VTRS	Drug Manufacturers - Specialty & Generic	1.48%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	Drug Manufacturers - Specialty & Generic	4.31%
Yipinhong Pharmaceutical Co Ltd Class A SHE:300723	Drug Manufacturers - Specialty & Generic	1.01%
Avadel Pharmaceuticals PLC NASDAQ:AVDL	Drug Manufacturers - Specialty & Generic	5.90%

Annual Asset Resilience Ratio for Bukwang Pharm (2007–2024)

The table below shows the annual Asset Resilience Ratio data for Bukwang Pharm.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	10.72%	₩40.00 Billion ≈ $27.11 Million	₩373.18 Billion ≈ $252.90 Million	+10.34pp
2021-12-31	0.38%	₩1.50 Billion ≈ $1.02 Million	₩397.42 Billion ≈ $269.32 Million	-2.19pp
2020-12-31	2.57%	₩10.30 Billion ≈ $6.98 Million	₩400.97 Billion ≈ $271.73 Million	-3.95pp
2014-12-31	6.51%	₩15.43 Billion ≈ $10.46 Million	₩236.82 Billion ≈ $160.49 Million	-2.28pp
2013-12-31	8.79%	₩20.07 Billion ≈ $13.60 Million	₩228.21 Billion ≈ $154.66 Million	+3.73pp
2008-12-31	5.06%	₩11.67 Billion ≈ $7.91 Million	₩230.55 Billion ≈ $156.24 Million	-8.07pp
2007-12-31	13.13%	₩28.24 Billion ≈ $19.14 Million	₩215.02 Billion ≈ $145.71 Million	--

pp = percentage points

About Bukwang Pharm

KO:003000 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$263.11 Million

₩388.25 Billion KRW

Market Cap Rank

#15535 Global

#528 in Korea

Share Price

₩3935.00

Change (1 day)

+0.13%

52-Week Range

₩3485.00 - ₩9600.00

All Time High

₩36947.85